These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3218657)

  • 21. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the renin-angiotensin system.
    Nicholls MG; Charles CJ; Crozier IG; Espiner EA; Ikram H; Rademaker MJ; Richards AM; Yandle TG
    J Hypertens Suppl; 1994 Dec; 12(10):S95-103. PubMed ID: 7769497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of ACE inhibition.
    Nussberger J; Waeber B; Brunner HR
    Cardiology; 1989; 76 Suppl 2():11-22. PubMed ID: 2670217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.
    Johnston CI
    J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of renal and extrarenal renin-angiotensin system in the mechanism of arterial hypertension and its sequelae.
    Rosenthal J
    Steroids; 1993 Dec; 58(12):566-72. PubMed ID: 8116011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?
    Lees KR; MacFadyen RJ; Reid JL
    Am J Hypertens; 1990 Nov; 3(11):266S-272S. PubMed ID: 2175623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of renin: an updated review of the development of renin inhibitors.
    Li YC
    Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall.
    Unger T; Gohlke P; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S8-16. PubMed ID: 2474111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin converting enzyme inhibitors and vascular remodelling in arterial hypertension].
    Garnier LF
    Ann Cardiol Angeiol (Paris); 1993 Oct; 42(8):438-44. PubMed ID: 8122853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
    Chin BS; Lip GY
    J Hum Hypertens; 2001 Feb; 15(2):89-92. PubMed ID: 11317186
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.
    Weber MA; Neutel JM; Smith DH
    Am Heart J; 1992 May; 123(5):1414-20. PubMed ID: 1575168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
    Laragh JH; Sealey JE
    Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Levenson J; Chau NP; Billaud E; Simon A
    Am J Cardiol; 1988 May; 61(13):1056-60. PubMed ID: 2834938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan NM
    J Am Soc Hypertens; 2015 Aug; 9(8):582-3. PubMed ID: 26319536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.